Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FDC”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02581553
What this trial is testing

Lesinurad/Allopurinol 200/300 FDC Tablets Bioavailability

Who this might be right for
Healthy
Ardea Biosciences, Inc. 116
Large-scale testing (Phase 3)Study completedNCT01977794
What this trial is testing

Fixed Dose Combination of Bisoprolol and Amlodipine in the Treatment of Hypertension

Who this might be right for
Hypertension
Merck KGaA, Darmstadt, Germany 200
Large-scale testing (Phase 3)Study completedNCT00673478
What this trial is testing

Tiotropium and Salmeterol PK Study in COPD Patients

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim 50
Early research (Phase 1)Study completedNCT02084082
What this trial is testing

Bioequivalence of a FDC Tablet of Linagliptin/Metformin (5mg/1000mg) Extended Release in Healthy Subjects

Who this might be right for
Healthy
Boehringer Ingelheim 68
Early research (Phase 1)Study completedNCT00961480
What this trial is testing

Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Co-administration of Sitagliptin and Metformin as Individual Tablets (0431A-095)

Who this might be right for
Type 2 Diabetes
Merck Sharp & Dohme LLC 24
Testing effectiveness (Phase 2)Study completedNCT03459222
What this trial is testing

An Investigational Study of Immunotherapy Combinations in Participants With Solid Cancers That Are Advanced or Have Spread

Who this might be right for
Advanced Cancer
Bristol-Myers Squibb 229
Testing effectiveness (Phase 2)Study completedNCT03623854
What this trial is testing

Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma

Who this might be right for
ChordomaLocally Advanced ChordomaMetastatic Chordoma+1 more
Jonsson Comprehensive Cancer Center 10
Large-scale testing (Phase 3)Study completedNCT01533935
What this trial is testing

Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients.

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim 291
Testing effectiveness (Phase 2)Study completedNCT00720499
What this trial is testing

Efficacy and Safety of 4 Weeks of Treatment With Orally Inhaled BI1744/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim 141
Large-scale testing (Phase 3)Study completedNCT01533922
What this trial is testing

Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim 295
Early research (Phase 1)Study completedNCT02966548
What this trial is testing

Safety Study of BMS-986016 With or Without Nivolumab in Patients With Advanced Solid Tumors

Who this might be right for
Cancer
Bristol-Myers Squibb 35
Early research (Phase 1)Study completedNCT01728740
What this trial is testing

Bioequivalence Study for Acarbose / Metformin FDC

Who this might be right for
Diabetes Mellitus, Type II
Bayer 40
Large-scale testing (Phase 3)Study completedNCT02431247
What this trial is testing

Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Fixed Dose Combination (FDC) Versus a Regimen Consisting of Darunavir/Cobicistat FDC With Emtricitabine/Tenofovir Disoproxil Fumarate FDC in Treatment-naive HIV Type 1 Infected Subjects

Who this might be right for
Immunodeficiency Virus Type 1, Human
Janssen Sciences Ireland UC 725
Early research (Phase 1)Looking for participantsNCT05645276
What this trial is testing

AK129 in Patients With Advanced Malignant Tumors

Who this might be right for
Advanced Malignant Tumors(Stage IA-IB)
Akeso 182
Not applicableLooking for participantsNCT06528613
What this trial is testing

Real World Study in Greek Patients with BPH for Disease Control and QoL Under FDC Treatment with Solifenacin/Tamsulosin.

Who this might be right for
Benign Prostatic Hyperplasia
Elpen Pharmaceutical Co. Inc. 450
Not applicableStudy completedNCT03144440
What this trial is testing

Real World Experience of Chronic Hepatitis C (CHC) Treatment in Israel

Who this might be right for
Hepatitis C
Carmel Medical Center 200
Not applicableApproved For MarketingNCT04395508
What this trial is testing

An Expanded Access Study to Provide at Home Subcutaneous Administration of Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Patients With HER2-Positive Breast Cancer During the COVID-19 Pandemic

Who this might be right for
HER2-positive Breast Cancer
Genentech, Inc.
Testing effectiveness (Phase 2)Study completedNCT05287113
What this trial is testing

Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Cancer
Incyte Biosciences International Sàrl 176
Large-scale testing (Phase 3)Study completedNCT02164513
What this trial is testing

A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 10,355
Early research (Phase 1)WithdrawnNCT04252768
What this trial is testing

A Study in Hormone Receptor-positive Metastatic Breast Carcinoma Patients to Test a New Schedule of Efti (IMP321, Eftilagimod Alpha) as Adjunctive to a Weekly Treatment Regimen of Paclitaxel

Who this might be right for
Metastatic Breast Cancer
Immutep S.A.S.
Next Page